A heart-wrenching story unfolds as two families from Kent, united by tragedy, come together to support a groundbreaking clinical trial. Their mission? To improve the treatment of child cancers and give hope to families facing similar battles.
'We witnessed our daughter's fight, and the system's limitations.'
Joshua Askew, reporting from the South East, brings us the story of Emma Giles and her five-year-old daughter, Eva. Eva's battle with a rare and aggressive brain tumour left the family reeling, thrust into a world of uncertainty and fear.
Emma shares, 'We had to watch our brave little girl endure radiotherapy, her head bolted to a table, waves of treatment penetrating her tiny body. It was a daily ordeal, and all we could hope for was more time.'
But time was not enough. Eva's diagnosis of a diffuse midline glioma left the family with a devastating prognosis - a cure was not an option.
'We knew we were going to lose our precious daughter, and the pain of that realization was unbearable,' Emma confesses.
However, their story doesn't end there. Emma, determined to make a difference, established Eva's Angels, a charity that has donated an incredible £791,000 to the trial. Joining forces with other charitable organizations, they aim to fund vital research.
But here's where it gets controversial...
The trial, coordinated by Cancer Research UK, will test drug combinations on newly diagnosed patients aged one to 25, based on the genetic characteristics of their brain cancers. The information gathered will help researchers understand treatment responses, a crucial step towards personalized medicine.
And this is the part most people miss...
Sarah and Ben Pullen, from Faversham, Kent, share a similar story. Their son, Silas, passed away from a high-grade glioma, a type of brain tumour, just 16 months after his diagnosis. They established The Silas Pullen Fund, raising over £1 million for the Brain Tumour Charity, which also supports the trial.
Sarah Pullen emphasizes, 'There are very few treatment options for paediatric brain tumours. We hope this trial will offer a glimmer of hope to families, giving them the chance to fight for their children's lives.'
The life expectancy for childhood brain cancers like diffuse midline glioma is a stark nine to twelve months, according to the Brain Tumour Charity.
This trial aims to change that.
So, what do you think? Is this trial a step towards a brighter future for children battling cancer? Or are there other factors we should consider? We'd love to hear your thoughts in the comments below. Let's spark a conversation and keep Eva, Silas, and all the brave children fighting cancer in our thoughts.
